IRRAS Receives US FDA 510(k) Clearance for its Next Generation IRRAflow Control Unit
· IRRAS received US FDA 510(k) clearance for its class II next-generation IRRAflow control unit that enhances the procedural workflow for health care professionals treating critically ill patients suffering from intracranial bleeds. · The cleared enhancements made to the next-generation IRRAflow control unit include additional functionality to the system’s user interface software that permits communication and data transmission to the hospital’s bedside monitor.Stockholm, December 12, 2022 – IRRAS, a commercial-stage medical technology company with a comprehensive portfolio of innovative